Soligenix, Inc. Files 8-K: Other Events & Financials
Ticker: SNGX · Form: 8-K · Filed: May 17, 2024 · CIK: 812796
| Field | Detail |
|---|---|
| Company | Soligenix, Inc. (SNGX) |
| Form Type | 8-K |
| Filed Date | May 17, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $2,500,000, $154,840, $4.75 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, financials
Related Tickers: SOLI
TL;DR
SOLI filed an 8-K for other events and financials - no new info yet, but keep an eye out.
AI Summary
On May 17, 2024, Soligenix, Inc. filed an 8-K report detailing "Other Events" and "Financial Statements and Exhibits." The filing does not disclose specific new events or financial figures but serves as a notification of these categories being addressed.
Why It Matters
This 8-K filing indicates that Soligenix, Inc. is providing updates or disclosures related to its financial statements and other material events, which is important for investors to monitor company activities.
Risk Assessment
Risk Level: low — The filing is a standard procedural update and does not contain information that inherently increases or decreases risk.
Key Players & Entities
- Soligenix, Inc. (company) — Filer of the 8-K report
- May 17, 2024 (date) — Date of the earliest event reported
- 001-14778 (other) — Commission File Number for Soligenix, Inc.
- 29 Emmons Drive, Suite B-10, Princeton, NJ 08540 (location) — Principal executive office address
FAQ
What specific "Other Events" are being reported by Soligenix, Inc. in this 8-K filing?
The filing does not specify the details of the "Other Events" beyond listing the category.
Are there any new financial statements or exhibits included with this 8-K filing?
The filing indicates that "Financial Statements and Exhibits" are part of the report, but the specific content is not detailed in the provided header information.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 17, 2024.
What is the Commission File Number for Soligenix, Inc.?
The Commission File Number for Soligenix, Inc. is 001-14778.
Where are Soligenix, Inc.'s principal executive offices located?
Soligenix, Inc.'s principal executive offices are located at 29 Emmons Drive, Suite B-10, Princeton, NJ 08540.
Filing Stats: 505 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2024-05-17 16:25:40
Key Financial Figures
- $2,500,000 — y have shareholders' equity of at least $2,500,000 as a result of (i) the conversion of $1
- $154,840 — 00 as a result of (i) the conversion of $154,840 of debt into equity on April 15, 2024 a
- $4.75 million — n April 15, 2024 and (ii) the Company's $4.75 million public offering, which closed on April
Filing Documents
- sngx-20240517x8k.htm (8-K) — 36KB
- 0001558370-24-008421.txt ( ) — 161KB
- sngx-20240517.xsd (EX-101.SCH) — 4KB
- sngx-20240517_def.xml (EX-101.DEF) — 3KB
- sngx-20240517_lab.xml (EX-101.LAB) — 17KB
- sngx-20240517_pre.xml (EX-101.PRE) — 10KB
- sngx-20240517x8k_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events Soligenix, Inc., a Delaware corporation (the "Company"), believes that as of the date of this Current Report on Form 8-K it is in compliance with The NASDAQ Stock Market's requirement that the Company have shareholders' equity of at least $2,500,000 as a result of (i) the conversion of $154,840 of debt into equity on April 15, 2024 and (ii) the Company's $4.75 million public offering, which closed on April 22, 2024. The equity financing and the debt conversion have been previously reported, including under Note 8. (Subsequent Events) to the Company's condensed consolidated financial statements for the quarter ended March 31, 2024 which were filed as part of the Company's Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 10, 2024.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Soligenix, Inc. May 17, 2024 By: /s/ Christopher J. Schaber Christopher J. Schaber, Ph.D. President and Chief Executive Officer (Principal Executive Officer) 3